Explore evidence

36 %Among 7,046 individuals sampled starting antiretroviral therapy (ART) in Kenya between April 2018 and March 2021, 36.0% started ART during April 2019–March 2020.

KenyaVIH/sidaobserved April 2019–March 2020published 2023PloS onePubMeddocument of 7 observations

120 individualsAmong 401 adolescent girls and young women enrolled, 120 (29.9%) initiated highly-effective contraception.

KenyaVIH/sidaobserved April 2022 to February 2023published 2024AIDS and behaviorPubMeddocument of 4 observations

9.84 per_1000_person-yearsHIV incidence among adults without HIV in Kisumu County, Kenya, was 9.84 per 1000 person-years between January 2017 and August 2021.

KenyaVIH/sidaobserved January 2017 to August 2021published 2026PloS onePubMeddocument of 7 observations

46 %Of 621 sex partners enrolled, 46% (284 of 621) were HIV-positive.

KenyaVIH/sidapublished 2020Sexually transmitted diseasesPubMeddocument of 4 observations

90.7 %Of the 589 partners newly diagnosed with HIV, 90.7% were linked to care.

KenyaVIH/sidaobserved 2021published 2024Journal of the International AIDS SocietyPubMeddocument of 15 observations

37.8 per_100_person-yearsAmong newly enrolled adolescents and youth living with HIV (AYLHIV) in Kenya between January 2016 and December 2017, the incidence of loss to follow-up (LTFU) was 37.8 per 100 person-years.

KenyaVIH/sidaobserved 2016-2017published 2023AIDS patient care and STDsPubMeddocument of 5 observations

15.6 %Among HIV-1 seropositive women prostitutes in Nairobi (Kenya), 15.6% had oral mucosal lesions.

Kenyaoral mucosal lesions · VIH/sidapublished 1989Journal of Oral Pathology and MedicineOpenAlexdocument of 8 observations

In a prospective, multicenter, open-label trial conducted at four sites in Kenya, dolutegravir treatment was noninferior to a regimen containing a ritonavir-boosted PI when patients with viral suppression were switched from a ritonavir-boosted PI-based regimen.

KenyaVIH/sidapublished 2023The New England journal of medicinePubMeddocument of 8 observations

64 %After 24 months, retention rates for the after 'test and treat' group were 64%.

KenyaVIH/sidapublished 2022PloS onePubMeddocument of 15 observations

19 %HIV counseling was conducted for 815 out of 4389 new family planning clients, representing 19%.

KenyaVIH/sidapublished 2019BMC health services researcheurope_pmcdocument of 6 observations

82 %School-based HIV and violence prevention and HIV testing and counselling were each accessed by 82% of early adolescent girls.

KenyaVIH/sidapublished 2021BMC public healthPubMeddocument of 6 observations

61.9 %Among viral failures on zidovudine (AZT)-based regimens, 61.9% had tenofovir disoproxil fumarate (TDF)-related drug resistance.

KenyaVIH/sidapublished 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 14 observations

49 %Among 100 pregnant women living with HIV in Western Kenya, 49% reported psychological/emotional health as a priority area affected by their HIV status.

KenyaVIH/sidapublished 2022BMC women's healthPubMeddocument of 5 observations

1.77 hazard_ratioPeople living with HIV on tenofovir/lamivudine/dolutegravir (TLD) had 1.77 times the hazard of developing a high BMI (≥25 kg/m²) compared to those on non-TLD antiretroviral therapy.

KenyaVIH/sidapublished 2022Journal of the International AIDS SocietyPubMeddocument of 4 observations

9 %Among 437 pregnant women living with HIV in western Kenya, 9% reported concern about isolation or lack of support from family or friends.

KenyaVIH/sidapublished 2020BMC pregnancy and childbirthPubMeddocument of 11 observations

4 %Among HIV-infected patients enrolled in the program in Central Kenya, those in WHO clinical stage IV decreased from 4.0% in 2004 to 1.1% in 2014.

KenyaVIH/sidaobserved 2004 to 2014published 2021BMC infectious diseasesPubMeddocument of 10 observations

74.7 %Among children and adolescents on antiretroviral therapy at Mbita Sub-County Hospital, 74.7% of those attending school achieved viral suppression compared to 68.8% of those not attending school.

KenyaVIH/sidaobserved October 2016 to September 2017published 2021African health sciencesPubMeddocument of 6 observations

62 individualsAmong 152 children with HIV, 40.8% (62) were tuberculosis–antiretroviral therapy treated.

Kenyatuberculose · VIH/sidapublished 2024AIDS (London, England)PubMeddocument of 5 observations

10.8 %At 3 years, 10.8% of children had unknown HIV/vital status.

KenyaVIH/sidapublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 13 observations

12,439 copies/mLThe mean HIV viral load among women with detectable viral load was 12,439 copies/mL.

KenyaVIH/sidapublished 2025International journal of STD & AIDSPubMeddocument of 8 observations

8.5 %HIV prevalence was 8.5% among men who have sex with men who solely met partners via physical sites (PMSM) in Kenya.

KenyaVIH/sidaobserved 2019published 2020Journal of the International AIDS SocietyPubMeddocument of 12 observations

151 participantsThe study included 151 HIV-1-seronegative Kenyan female sex workers.

KenyaVIH/sidapublished 2008Sexually transmitted diseaseseurope_pmcdocument of 5 observationsDOI 10.1097/olq.0b013e31816907fa

93,179 facility-records93,179 facility-records from 11,446 health facilities were extracted from DHIS2 for HIV-data in Kenya from 2011 to 2018.

KenyaVIH/sidaobserved 2011 to 2018published 2020BMC medical informatics and decision makingPubMeddocument of 5 observations

0.3 personsThe microclinic intervention increased HIV status disclosure to close social supports by +0.3 persons over one year of follow-up.

KenyaVIH/sidaobserved one year of follow-uppublished 2021PloS onePubMeddocument of 9 observations

91.9 %Among virally suppressed AYPLHIV at baseline enrolled in Operation Triple Zero (OTZ), 91.9% of females sustained viral load suppression (VLS).

KenyaVIH/sidapublished 2025The Journal of adolescent health : official publication of the Society for Adolescent MediPubMeddocument of 9 observations